Showing results (151-160 of 242) with videos related to
Sort By:
Pageof 25
Clinical Lung Cancer|October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung CancerAakash Desai, Caleb J Smith, Yash Ashara, et al.Anti-Cancer Drugs|September 1, 2017
Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancerShannon C Leonard, Helen Lee, Daniel F Gaddy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Lack of association between sputum atypia and chronic obstructive pulmonary disease mortalityYork E Miller, Kieu O Vu, Tim C Kennedy, et al.Cancer Treatment and Research Communications|August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief reportAakash Desai, Sagar Rakshit, Radhika Bansal, et al.JTO Clinical and Research Reports|November 24, 2025
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLCArthi Sridhar, Aditi Singh, Scott Hansen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR InhibitionHannah A Scarborough, Barbara A Helfrich, Matias Casás-Selves, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary diseaseYork E Miller, Patrick Blatchford, Dae Sung Hyun, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancerKaren Kelly, John Kittelson, Wilbur A Franklin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumorsDaniel C Chan, Keith A Earle, Tom L M Zhao, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificityTim Byers, Holly J Wolf, Wilbur A Franklin, et al.Pageof 25